Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.
Wang N, Hu X, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J, Huang L.
Wang N, et al. Among authors: wang g, wang d, wang q.
Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017.
Blood. 2020.
PMID: 31697824
Free article.
Clinical Trial.